Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (31-40 of 426) with videos related to

Pageof 43
Sort By:
The Lancet. Diabetes & Endocrinology|April 26, 2020
Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?Angelo Avogaro, Gian Paolo Fadini
International Journal of Cardiology|March 6, 2019
Microvascular complications in diabetes: A growing concern for cardiologistsAngelo Avogaro, Gian Paolo Fadini
Diabetes Care|February 18, 2006
Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetesGian Paolo Fadini, Angelo Avogaro
Journal of the American College of Cardiology|December 19, 2006
The Janus face of nicotinic angiogenesisAngelo Avogaro, Gian Paolo Fadini
Atherosclerosis|May 7, 2013
Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyondGian Paolo Fadini, Angelo Avogaro
European Journal of Heart Failure|May 29, 2021
A simple way to spotlight hidden heart failure in type 2 diabetes?Gian Paolo Fadini, Angelo Avogaro
European Journal of Heart Failure|March 9, 2018
Insulin treatment in patients with diabetes and heart failure: defendant on the standAngelo Avogaro, Gian Paolo Fadini
International Journal of Cardiology|November 27, 2012
Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysisGian Paolo Fadini, Angelo Avogaro
Diabetes Care|September 25, 2014
The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complicationsAngelo Avogaro, Gian Paolo Fadini
British Journal of Clinical Pharmacology|April 19, 2018
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitorsAngelo Avogaro, Gian Paolo Fadini
Pageof 43

Showing results (31-40 of 426) with videos related to

Sort By:
Pageof 43
The Lancet. Diabetes & Endocrinology|April 26, 2020
Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?Angelo Avogaro, Gian Paolo Fadini
International Journal of Cardiology|March 6, 2019
Microvascular complications in diabetes: A growing concern for cardiologistsAngelo Avogaro, Gian Paolo Fadini
Diabetes Care|February 18, 2006
Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetesGian Paolo Fadini, Angelo Avogaro
Journal of the American College of Cardiology|December 19, 2006
The Janus face of nicotinic angiogenesisAngelo Avogaro, Gian Paolo Fadini
Atherosclerosis|May 7, 2013
Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyondGian Paolo Fadini, Angelo Avogaro
European Journal of Heart Failure|May 29, 2021
A simple way to spotlight hidden heart failure in type 2 diabetes?Gian Paolo Fadini, Angelo Avogaro
European Journal of Heart Failure|March 9, 2018
Insulin treatment in patients with diabetes and heart failure: defendant on the standAngelo Avogaro, Gian Paolo Fadini
International Journal of Cardiology|November 27, 2012
Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysisGian Paolo Fadini, Angelo Avogaro
Diabetes Care|September 25, 2014
The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complicationsAngelo Avogaro, Gian Paolo Fadini
British Journal of Clinical Pharmacology|April 19, 2018
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitorsAngelo Avogaro, Gian Paolo Fadini
Pageof 43